Trials in primary and secondary prevention of coronary heart disease (CHD) are reviewed. The results of completed primary prevention trials suggest that dietary changes in middle-aged men may lower the incidence of CHD. Multifactorial trials may achieve an even greater reduction in CHD. Secondary prevention trials indicate that stopping smoking and the use of betablocking agents are effective in reducing recurrence rates.
Introduction
The arguments for a preventive approach to coronary heart disease (CHD) arise from the present size of the problem and its changing age pattern, from the realization that medical or surgical intervention is unlikely to affect the overall mortality and from the nature of the underlying disease process. In this presentation, the size and nature of the coronary heart disease problem in the U.K. and the present status of prevention trials in general will briefly be examined. We will then try to assess what more can be done in both primary and secondary prevention. Fundamental to the preventive approach is the belief that CHD is not an inevitable consequence of ageing or affluence and that its impact on our society can be considerably diminished.
CHD as a cause of death in the U.K.
If we examine the causes of death in men aged 45-54 years of age in England and Wales, we see that 510% of male deaths are cardiovascular (CVD); three-quarters of these are due to CHD. By comparison, cancer (27 %) and accidents (7 %) contribute considerably less to total mortality. Even in the 35-44 year age group, CVD accounts for 41 % of all male deaths and again, three-quarters of these are due to coronary heart disease ( Fig. 1) . Within the U.K. there are such marked regional differences that, in assessing the size of the problem, we must consider England and Wales, Scotland and Northern Ireland as separate entities, at least from a CHD point of view. Figure 2 shows the annual death rates for CHD in men at three age levels (35-44, 45-54 and 55-64 years) and at three periods in time (1950, 1960 and 1970) . In all three age groups and for each time period Scottish (Fig. 3) . The two older age groups show a 50 % and 25 % increase respectively, which is just as well for total mortality, bearing in mind the rates at these ages. Scottish men have shown a 75 % increase in the younger age group, but as their rate is already much higher than the English/ Welsh rate, this lower rate of increase must be very cold comfort to the Scots.
The community view
Studies from Oxford, Edinburgh and London of myocardial infarction and sudden death in defined communities make it possible for us to see CHD as it really is, and not as it appears from the hospital or the coronary care unit (Kinlen, 1969; Armstrong et al., 1972; Pedoe, 1975) . In these three community studies, nearly two-thirds of fatal attacks were medically unattended. Most deaths occurred at the place of onset of symptoms, usually home or at work, and only one-third took place in hospital. The majority of coronary deaths occurring within 28 days of the onset of the attack take place within 1 hr and most of these at the beginning of that hour.
Coronary 35-44, 33-3; 45-54, 167-3; 55-64, 598 6; Scotland, 35-44, 53 0; 45-54, 247-7; 55-64, 754 7 (DHSS, 1974 Primary prevention trials Some of the major trials designed to prevent coronary heart disease will now be described and their findings reviewed. They all have had serious criticism directed against them; what remains remarkable is that despite their limitations they all provide evidence which points in the same positive and possibly encouraging direction.
New York anti-coronary club (Christakis et al., 1966; Rinzler, 1968) This study started in 1957, and enrolled in its experimental group 941 free living men aged 40-59 years and free of clinical coronary heart disease. Two years later, in 1959, a comparison group of 457 men was recruited. The study dealt primarily with alterations in nutritional habits (reduction of fat calories to 30-33 % and substituting polyunsaturated for saturated fatty acids) and aimed at reducing blood cholesterol and also reducing weight in those volunteers who were obese. The results at 10 and 12 years are shown in Table 1 , presented on a personyear basis for those who were actively involved covering the period of their active involvement, separately for those who lapsed into inactivity, and also for the comparison group. Criticisms of this study include the fact that control subjects were not selected from the same population as the test subjects or at the same time and that there is no information regarding other changes (e.g. exercise) which these 'coronary conscious' volunteers might have made. Los Angeles veterans administration study (Dayton et al., 1969) This is probably the best study so far in the whole difficult field of diet and blood cholesterol but it is a mixed primary and secondary prevention study; 846 men aged over 55 years (average age 65 years) living in an institution ( Table 2 ). The groups were properly randomized, ate in different canteens and were to some extent supervised. The experimental group was given a diet rich in polyunsaturated fatty acids and the control group the ordinary American diet. The results were encouraging if not conclusive; sixty coronary events in the diet group and seventy-eight in the control group (not statistically significant). Inclusion of cerebral infarction and other endpoints produced a result significant at the 1 % level, but it is a matter of opinion as to whether these groups should be included. This study was conducted in a particularly elderly group. Although most of the differences between the two groups in the study occurred under the age of 65 years, the numbers at these younger ages were not large enough to provide significant results. Another disadvantage was that the subjects were institutionalized and so we learn little or nothing about the practicality and adherence to such a regime of freeliving men. The inclusion of subjects with previous myocardial infarction or angina pectoris also makes the result difficult to evaluate.
The Finnish mental hospitals study (Miettinen et al., 1972) This well known trial is also of considerable interest and again is both primary and secondary (Table  3) . It is very difficult to determine from the data (Stamler, 1971) A somewhat different approach is that which aims at high-risk subjects only and is multifactorial in its modification programme (Table 4 proper control group and it is concerned with a volunteer group of 'coronary conscious' subjects. Nevertheless, the results are quite strikint.
Cancer, gail-bladder disease and PUFA The possibility that the increased level of polyunsaturated fatty acids (PUFA) in the diet could lead to an increased incidence of cancer was raised by the Los Angeles VA study (Pearce and Dayton, 1971 ). Comparison of the cancer incidence in four other clinical trials of blood cholesterol lowering diets did not support this finding and the combined results of the five studies were consistent with the hypothesis that the diets do not influence cancer risk (Ederer et al., 1971; Heady, 1974) .
The VA study also indicated an increased incidence of gall-stones in patients on the PUFA diets, but the Finnish mental hospital study did not show any such effect.
Comment on primary prevention
The gain in knowledge for the vast amount of work expended is not very impressive and one must reluctantly agree with those who point out that the sounder the methodology and the harder the endpoints, the less conclusive are the results.
While none of the reported trials is free from one or other important deficiency, the overall effect of the results does permit a conclusion that dietary manipulations in middle-aged or elderly men may lower the incidence of CHD, and that multifactorial intervention may produce a greater reduction in CHD mortality.
There is at present in progress a WHO-sponsored multifactorial primary prevention study with participating groups from Belgium, Italy, Poland and the U.K. (WHO European Collaborative Group, 1974) . The recommendations include a diet for lowering blood cholesterol, stopping of cigarette smoking, weight reduction, treatment of hypertension and daily physical exercise. Bearing in mind the vicissitudes and criticisms of all previous studies, the collaborators may be excused their hope that, 'if fortune favours us, we may finish up with a firm conclusion'.
Secondary prevention
Over the past 10 years there have been a number of studies designed to prevent death or recurrent myocardial infarction in patients already known to have coronary heart disease. The earlier studies were based on the lowering of blood cholesterol by dietary means and the results were an unhappy mixture of encouragement and disappointment (Research Committee, 1965; Rose, Thomson and Williams, 1965; Leren, 1970; MRC Research Committee, 1968; Bierenbaum, 1973 (Coronary Drug Project Research Group, 1975) . In summary, neither drug produced any significant improvement in total mortality or coronary heart disease mortality and both drugs were associated with an increased incidence of several cardiovascular events.
The American Coronary Drug Project also showed that the 5-year incidence of gall-stones was 3 % in myocardial infarction patients treated with clofibrate compared with 1-3 % in the control group. It is known that clofibrate increases the excretion of cholesterol through the biliary tract (Grundy et al., 1972) and increases the lithogenicity of bile (Pertsemlidis, Panveliwalla and Ahrens, 1974) so that this result is not altogether surprising. Data from the international trial of the primary prevention of IHD using clofibrate (Heady, 1973) also show an increased incidence of cholecystectomy for gall-stones in the clofibrate group, but the 5-year rate is only 1 % (Cooper, Geizeroza and Oliver, 1975) .
Aspirin and coronary heart disease The results of a randomized controlled trial of a single daily dose of aspirin in the prevention of reinfarction in Wales and England were inconclusive (Elwood et al., 1974) . In three centres mortality was higher in the placebo group and in two centres it was higher in the aspirin group. The differences between the death rate curves were small but the death rate in the placebo group was always higher than in the aspirin group. On the other hand, the results of two large independent studies in the United States were consistent with the hypothesis that aspirin does protect against recurrence of CHD events (Boston Collaborative Drug Surveillance Group, 1974) . More recently a prospective study in the U.S.A. of over 1 million men and women has shown that CHD death rates were no lower among people who took aspirin often than among those who did not do so (Hammond and Garfinkel, 1975 (Norris et al., 1973; Vedin, Wilhelmsson and Werko, 1975; Mulcahy et al., 1975) . However, plasma lipids, cigarette smoking and physical inactivity continue to make some contribution to the assessment of prognosis (Coronary Drug Project Research Group, 1974) . Mortality has been shown to be reduced in patients who stop smoking after a CHD event and treatment with a betablocking agent (alprenolol) has also been shown to reduce mortality after myocardial infarction, especially mortality from sudden death (Wilhelmsson et al., 1974) . Physical training programmes have also been promoted and are a fairly expensive method of treatment with a high drop-out rate, and although the risk of serious complications is not great they are not completely safe (Blackburn, 1974) . Anyway, the secondary preventive effect is small; far less than from stopping smoking or using a betablocking drug. In general, it would seem that active encouragement to return to work, advice to stop smoking, simple dietary recommendations to lower blood lipids and reduce weight, control of high blood pressure and light unsupervised exercise are likely in combination to achieve the best results in secondary prevention.
Conclusion
It seems unlikely that the proof required to establish conclusively that a particular dietary regime is critical to the primary prevention of CHD will be provided in the foreseeable future. The present series of multifactorial trials may result in a reduction of coronary heart disease, but cannot indicate which of the many factors employed are of critical importance. However, let us not confuse our aims. On the one hand there is the search for a complete understanding of the aetiology and pathogenesis of the disease and on the other there is a need to apply what we already know to the prevention of the disease. The latter need not wait upon the former-it has rarely done so in the history of medicine. Continued research into the aetiology and pathogenesis of CHD is vital, but we know enough at present to make an attempt at least to prevent the disease which we know we cannot cure. Let this paper end with a quotation from Francis Bacon, who some 400 years ago provided a reasonable approach to the primary prevention of CHD: 'Examine thy customs of diet, sleep, exercise, apparel and the like; and try, if anything thou shalt find hurtful, to discontinue it by little and little; but so if thou dost find any inconvenience by the change, then come back to it again'.
